DCM
ELV icon

Delpha Capital Management’s Elevance Health ELV Stock Holding History

Delpha Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-246
Closed -$55K – 440
2017
Q4 		$55K Buy
+246
New +$52.4K 0.06% 272

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Delpha Capital Management's ELV Position: Q1 2018 in Review

Delpha Capital Management sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 246 shares — an estimated $55K sold.

Delpha Capital Management first reported a position in ELV in Q4 2017 and held it in 1 quarter. The position peaked at $55K in Q4 2017. 923 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • Delpha Capital Management reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 246 Elevance Health shares in Q1 2018, an estimated $55K.
  • Delpha Capital Management first reported a position in Elevance Health in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Elevance Health position peaked at $55K in Q4 2017.
  • 923 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.